2nd Quarter - Report

AGILON HEALTH, INC. for AGILON HEALTH, INC.

Firm
Client
Income
—
Expenses
$100,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues related to value-based health care, including Medicare Advantage (MA) and ACO models; Medicare Shared Savings Program (MSSP) and SCO REACH Model; LEAD Model; MA data sharing; physician reimbursement and Medicare and CHIP Reauthorization Act (MACRA)-related policies (PL 114-10), including APM bonus payments; HR.8129, To amend title XVIII of the Social Security Act to establish a full risk ACO program, full-risk legislation; and related CMS innovation and payment model activities through CMMI.

LobbyistCovered position, as disclosed
KATIE BOYER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 8129 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.